Your browser doesn't support javascript.
loading
The paracaspase MALT1 cleaves HOIL1 reducing linear ubiquitination by LUBAC to dampen lymphocyte NF-κB signalling.
Klein, Theo; Fung, Shan-Yu; Renner, Florian; Blank, Michael A; Dufour, Antoine; Kang, Sohyeong; Bolger-Munro, Madison; Scurll, Joshua M; Priatel, John J; Schweigler, Patrick; Melkko, Samu; Gold, Michael R; Viner, Rosa I; Régnier, Catherine H; Turvey, Stuart E; Overall, Christopher M.
Afiliação
  • Klein T; Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia, Canada V6T 1Z3.
  • Fung SY; Department of Oral Biological and Medical Science, University of British Columbia, Vancouver, British Columbia, Canada V6T 1Z3.
  • Renner F; Center for Blood Research, University of British Columbia, Vancouver, British Columbia, Canada V6T 1Z3.
  • Blank MA; Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada V6T 1Z3.
  • Dufour A; Child &Family Research Institute, BC Children's Hospital, Vancouver, British Columbia, Canada V6T 1Z3.
  • Kang S; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, CH-4056, Switzerland.
  • Bolger-Munro M; Thermo Fisher Scientific, 355 River Oaks Parkway, San Jose, 95134 California, USA.
  • Scurll JM; Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia, Canada V6T 1Z3.
  • Priatel JJ; Department of Oral Biological and Medical Science, University of British Columbia, Vancouver, British Columbia, Canada V6T 1Z3.
  • Schweigler P; Child &Family Research Institute, BC Children's Hospital, Vancouver, British Columbia, Canada V6T 1Z3.
  • Melkko S; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada V5Z 4H4.
  • Gold MR; Department of Microbiology and Immunology, University of British Columbia, Vancouver, British Columbia, Canada V6T 1Z3.
  • Viner RI; Department of Mathematics, University of British Columbia, Vancouver, British Columbia, Canada V6T 1Z3.
  • Régnier CH; Child &Family Research Institute, BC Children's Hospital, Vancouver, British Columbia, Canada V6T 1Z3.
  • Turvey SE; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada V5Z 4H4.
  • Overall CM; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, CH-4056, Switzerland.
Nat Commun ; 6: 8777, 2015 Nov 03.
Article em En | MEDLINE | ID: mdl-26525107
ABSTRACT
Antigen receptor signalling activates the canonical NF-κB pathway via the CARD11/BCL10/MALT1 (CBM) signalosome involving key, yet ill-defined roles for linear ubiquitination. The paracaspase MALT1 cleaves and removes negative checkpoint proteins, amplifying lymphocyte responses in NF-κB activation and in B-cell lymphoma subtypes. To identify new human MALT1 substrates, we compare B cells from the only known living MALT1(mut/mut) patient with healthy MALT1(+/mut) family members using 10-plex Tandem Mass Tag TAILS N-terminal peptide proteomics. We identify HOIL1 of the linear ubiquitin chain assembly complex as a novel MALT1 substrate. We show linear ubiquitination at B-cell receptor microclusters and signalosomes. Late in the NF-κB activation cycle HOIL1 cleavage transiently reduces linear ubiquitination, including of NEMO and RIP1, dampening NF-κB activation and preventing reactivation. By regulating linear ubiquitination, MALT1 is both a positive and negative pleiotropic regulator of the human canonical NF-κB pathway-first promoting activation via the CBM--then triggering HOIL1-dependent negative-feedback termination, preventing reactivation.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos / NF-kappa B / Caspases / Ubiquitina-Proteína Ligases / Síndromes de Imunodeficiência / Proteínas de Neoplasias Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos / NF-kappa B / Caspases / Ubiquitina-Proteína Ligases / Síndromes de Imunodeficiência / Proteínas de Neoplasias Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2015 Tipo de documento: Article